These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1004 related items for PubMed ID: 8758928

  • 1. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 2. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP.
    Cancer Res; 1995 Jul 01; 55(13):2822-30. PubMed ID: 7796409
    [Abstract] [Full Text] [Related]

  • 3. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.
    Elstner E, Linker-Israeli M, Le J, Umiel T, Michl P, Said JW, Binderup L, Reed JC, Koeffler HP.
    J Clin Invest; 1997 Jan 15; 99(2):349-60. PubMed ID: 9006004
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y, Chang RL, Cui XX, Newmark HL, Conney AH.
    Oncol Res; 1997 Jan 15; 9(1):19-29. PubMed ID: 9112257
    [Abstract] [Full Text] [Related]

  • 5. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP.
    Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293
    [Abstract] [Full Text] [Related]

  • 6. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R.
    Br J Pharmacol; 1997 Mar 15; 120(6):1119-27. PubMed ID: 9134225
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
    Dipietrantonio A, Hsieh TC, Wu JM.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):837-42. PubMed ID: 8713132
    [Abstract] [Full Text] [Related]

  • 9. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C, Abe E, Suda T, Kuroki T.
    Cancer Res; 1985 Sep 25; 45(9):4244-8. PubMed ID: 2992776
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ, Reddy GS, Koeffler HP.
    J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
    Zheng X, Chang RL, Cui XX, Kelly KA, Shih WJ, Lin Y, Strair R, Suh J, Han ZT, Rabson A, Conney AH.
    Oncol Res; 2000 Sep 01; 12(9-10):419-27. PubMed ID: 11697820
    [Abstract] [Full Text] [Related]

  • 12. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
    Sokoloski JA, Shyam K, Sartorelli AC.
    Oncol Res; 1997 Sep 01; 9(1):31-9. PubMed ID: 9112258
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
    Chapekar MS, Hartman KD, Knode MC, Glazer RI.
    Mol Pharmacol; 1987 Feb 01; 31(2):140-5. PubMed ID: 3100942
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis by momordin I in promyelocytic leukemia (HL-60) cells.
    Kim JH, Ju EM, Lee DK, Hwang HJ.
    Anticancer Res; 2002 Feb 01; 22(3):1885-9. PubMed ID: 12168888
    [Abstract] [Full Text] [Related]

  • 15. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60.
    Grillier I, Umiel T, Elstner E, Collins SJ, Koeffler HP.
    Leukemia; 1997 Mar 01; 11(3):393-400. PubMed ID: 9067579
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.
    Oncol Res; 1998 Mar 01; 10(6):313-24. PubMed ID: 9848102
    [Abstract] [Full Text] [Related]

  • 17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Mar 01; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 18. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
    Okazaki T, Mochizuki T, Tashima M, Sawada H, Uchino H.
    J Cell Physiol; 1987 Apr 01; 131(1):50-7. PubMed ID: 3032994
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the cytochrome P-450 modulates all-trans-retinoic acid-induced differentiation and apoptosis of HL-60 cells.
    Hofmanová J, Soucek K, Dusek L, Netíková J, Kozubík A.
    Cancer Detect Prev; 2000 Apr 01; 24(4):325-42. PubMed ID: 11059564
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.